2 Sep 2025 (84 Days) Date | | - Cons. EPS | - EPS |
24 Feb 2025 Date | | - Cons. EPS | - EPS |
4 Sep 2024 Date | | - Cons. EPS | - EPS |
9 Aug 2024 Date | | - Cons. EPS | - EPS |
31 Oct 2016 Date | | - Cons. EPS | - EPS |
2 Sep 2025 (84 Days) Date | | - Cons. EPS | - EPS |
24 Feb 2025 Date | | - Cons. EPS | - EPS |
4 Sep 2024 Date | | - Cons. EPS | - EPS |
9 Aug 2024 Date | | - Cons. EPS | - EPS |
31 Oct 2016 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Scott A. Cox CEO | OTC PINK Exchange | 87248Q101 Cusip |
US Country | 1 Employees | - Last Dividend | 10 Dec 2018 Last Split | - IPO Date |
THC Therapeutics, Inc. is a company that has positioned itself within the wellness industry with a primary focus on innovative solutions for the cannabis sector. Initially named Millennium Blockchain, Inc., the company underwent a name change to THC Therapeutics, Inc. in September 2018, signaling a new strategic direction towards cannabis-related products. Founded in 2007, the company makes its home in Las Vegas, Nevada, where it dedicates its efforts towards developing technologies aimed at the drying and sanitizing of freshly harvested cannabis, along with other herbs, flowers, and tea leaves.
The core product of THC Therapeutics, Inc. is: